TruAlt Bioenergy Share Price: Revenue **70%** Bhaga, Par Margins Mein Lagi Thokar! Kya Hoga Aage?

ENERGY
Whalesbook Logo
AuthorAarav Shah|Published at:
TruAlt Bioenergy Share Price: Revenue **70%** Bhaga, Par Margins Mein Lagi Thokar! Kya Hoga Aage?
Overview

TruAlt Bioenergy ne Q3 FY26 mein kamaal kar diya revenue ke maamle mein! Company ka consolidated revenue **70.20%** bhadkar **₹720.72 crore** ho gaya. Lekin haan, thodi gadbad margins mein ho gayi, jo **29.23%** se gir kar **18.36%** par aa gaye. Is wajah se, consolidated PAT bhi **8.79%** kam hokar **₹66.02 crore** raha. Management keh rahi hai ki ye sab 'transitional operating factors' hain.

📉 The Financial Deep Dive

Yeh jo revenue mein itni badi tezi aayi na, uska main reason hai ethanol business ka consolidation aur company ke plants ka fully operational ho jaana. Company ne Q3 FY26 mein consolidated revenue 70.20% year-on-year (YoY) badha kar ₹720.72 crore kar diya. Unke paanch mein se chaar ethanol plants ab 95% se zyada capacity utilization par chal rahe hain, jisse monthly production 5.5 se 6 crore litre tak pahunch gaya hai. Saath hi, grain-based integration ke liye jo planned capital expenditure tha, woh bhi ab poora kaam mein lag gaya hai.

Ab aate hain margins par. Consolidated EBITDA toh 8.41% YoY badhkar ₹129.05 crore tak pahuncha, lekin EBITDA margin mein kaafi girawat aayi hai. Yeh 29.23% se kam hokar 18.36% par aa gaya hai Q3 FY26 mein. Iska seedha asar consolidated Profit After Tax (PAT) par pada, jo 8.79% kam hokar ₹66.02 crore ho gaya. Company ka kehna hai ki ye sab naye plants set up karne aur integration mein hone wale 'transitional operating factors' hain, aur unhe yakin hai ki future mein performance stable rahegi.

Agar hum 9 mahine (ending December 31, 2025) ki baat karein, toh total income 13.28% YoY badhkar ₹1,187.05 crore hui, aur PAT mein 2.79% YoY ka halka sa rise tha, jo ₹35.92 crore raha.

🚀 Strategic Analysis & Impact

Future ki baat karein toh, Compressed Biogas (CBG) segment ekdum zabardast chal raha hai, jismein 63% ka EBITDA margin hai 9 mahine ke liye. TruAlt ka plan hai ki Sumitomo Corporation aur GAIL ke saath milkar aane wale 2 se 3 saalon mein 24 naye greenfield CBG units lagayein. Government policies bhi isko support kar rahi hain.

Sustainable Aviation Fuel (SAF) segment mein bhi kaam chal raha hai. Honeywell UOP ke saath tech licensing ho gayi hai aur ek 100 million litres per annum facility ke liye design work chal raha hai. Sumitomo Corporation se potential equity participation ki baatein bhi chal rahi hain. Aur haan, PM JI-VAN scheme ke under ₹150 crore ka viability gap funding bhi milne ki ummeed hai.

Biofuel retail segment mein ab tak saat outlets shuru ho gaye hain, aur FY27 se lagbhag 75 outlets tak pahunchne ka target hai. Company ab Distillers Dried Grains with Solubles (DDGS) aur green CO2 mein bhi explore kar rahi hai, matlab diversification ka full plan hai.

🚩 Risks & Outlook

Sabse bada point jisko dekhna hoga, woh hai ye margin compression. Agar ye continue raha toh problem ho sakti hai. Lekin company ke plans bade hain – CBG, SAF expansion, aur retail outlets ka rollout. Investors ko ab aane wale quarters mein margins stable hote hue dikhne chahiye. Agar company apne targets achieve kar leti hai, toh India ki energy security mein yeh company bada role play kar sakti hai, bas margins ko control mein rakha jaye.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.